TRINCHERA, MARCO GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.349
EU - Europa 2.015
AS - Asia 588
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.957
Nazione #
US - Stati Uniti d'America 3.347
IT - Italia 986
UA - Ucraina 371
TR - Turchia 261
SE - Svezia 205
VN - Vietnam 184
GB - Regno Unito 123
CN - Cina 108
IE - Irlanda 104
DE - Germania 99
FI - Finlandia 92
FR - Francia 16
IN - India 15
KR - Corea 13
BE - Belgio 10
AU - Australia 3
NL - Olanda 3
CA - Canada 2
HK - Hong Kong 2
HR - Croazia 2
IL - Israele 2
JP - Giappone 2
RU - Federazione Russa 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
GR - Grecia 1
PH - Filippine 1
Totale 5.957
Città #
Milan 748
Fairfield 474
Woodbridge 381
Jacksonville 292
Ashburn 282
Chandler 281
Houston 214
Seattle 209
Ann Arbor 204
Wilmington 199
Cambridge 160
Izmir 122
Dong Ket 108
Princeton 108
Dearborn 107
Nyköping 103
Dublin 101
Rome 55
Enfield 37
San Diego 36
Como 33
San Mateo 30
Beijing 26
Ogden 20
Nanjing 16
Pune 15
Düsseldorf 14
London 14
Hefei 13
Phoenix 12
Frankfurt am Main 11
Brussels 10
Kunming 10
Boardman 8
Jinan 8
Auburn Hills 7
Berlin 7
Falls Church 7
Redmond 7
Verona 7
Washington 7
Helsinki 6
Los Angeles 6
Bologna 5
Cardiff 5
Seongnam 5
Acton 4
Norwalk 4
Prescot 4
Chiswick 3
Guangzhou 3
New York 3
Paris 3
Ponte Lambro 3
Seoul 3
Siziano 3
Xian 3
Albuquerque 2
Central 2
Chicago 2
Hangzhou 2
Indiana 2
Islington 2
Jerusalem 2
Nanning 2
Quzhou 2
Shanghai 2
Shenyang 2
Zagreb 2
Amsterdam 1
Appleton 1
Bungarribee 1
Chengdu 1
Fuzhou 1
Giussano 1
Harbin 1
Hebei 1
Huzhou 1
Jiaxing 1
Kilburn 1
Kocaeli 1
Lanzhou 1
Manila 1
Mcallen 1
Menlo Park 1
Miami Beach 1
Milwaukee 1
Nanchang 1
New Bedfont 1
Ottawa 1
Providence 1
San Jose 1
Shaoxing 1
Stockholm 1
Sydney 1
Thessaloníki 1
Tokushima 1
Toronto 1
Vienna 1
Wandsworth 1
Totale 4.621
Nome #
Instability of cytosolic phospholipase A2α variant upon cellular expression as a basis for its clinical presentation 216
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers 188
Epigenetic Bases of Aberrant Glycosylation in Cancer 175
The expanding roles of the Sda/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2 171
Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation 169
Uptake, cell penetration and metabolic processing of exogenously administered GM1 ganglioside in rat brain 158
B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. 156
Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency 154
Comparative analysis of retroviral and native promoters driving expression of β1,3-galactosyltransferase β3Gal-T5 in human and mouse tissues 151
Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver 148
Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids 142
Inhibition of cholesterol biosynthesis in freshly isolated blood mononuclear cells from normolipidemic subjects and hypercholesterolemic patients treated with bezafibrate 140
Molecular cloning, expression, chromosomal assignment, and tissue-specific expression of a murine a-(1,3)-fucosyltransferase locus corresponding to the human ELAM-1 ligand fucosyl transferase 137
CA19.9 antigen circulating in the serum of colon cancer patients: Where is it from? 134
Extensive precursor-product relationship between gangliosides formed from exogenous glucosylceramide in rat liver 132
b1,3-galactosyltransferase b3Gal-T5 acts on the GlcNAc b1-3Galb1-4GlcNAcb1-R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins, and is down-regulated in colon adenocarcinomas 132
Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation 132
The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach 131
Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression 128
Control of Glycosylation-Related Genes by DNA Methylation: the Intriguing Case of the B3GALT5 Gene and Its Distinct Promoters 125
The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver 122
Protein kinase C modulates NMDA receptors in the myenteric plexus of the guinea pig ileum during in vitro ischemia and reperfusion 121
The link between gaucher disease and parkinson’s disease sheds light on old and novel disorders of sphingolipid metabolism 120
DNA methylation and histone modifications modulate the β1,3 galactosyltransferase β3Gal-T5 native promoter in cancer cells 120
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation 116
Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements 115
b1,3-galactosyltransferase and a1,2-fucosyltransferase involved in the biosynthesis of type 1 chain carbohydrate antigens in human adenocarcinoma cell lines 103
Dictyostelium cytosolic fucosyltransferase synthesizes H type I trisaccharide in vitro 96
Mechanisms of cancer-associated glycosylation changes 96
Complementary use of carbohydrate antigens lewis a, lewis b, and sialyl-lewis a (Ca19.9 epitope) in gastrointestinal cancers: Biological rationale towards a personalized clinical application 96
Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry 94
Expression of carbohydrate-antigen sialyl-Lewis a on colon cancer cells promotes xenograft growth and angiogenesis in nude mice 89
Altered expression and phosphorylation of NMDA NR1 subunits in the myenteric plexus during hypoxia-hypoglycaemia 88
Sub-Golgi distribution in rat liver of CMP-NeuAc: GM3- and CMP-NeuAc: GT1b alpha2-8 sialyltransferases and comparison with the distribution the other glycosyltransferase activities involved in ganglioside biosynthesis 87
A part of glucosylceramide formed from exogenous lactosylceramide is not degraded to ceramide but re-cycled and glycosylated in the Golgi apparatus 87
Suppression of beta1,3galactosyltransferase beta3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly-N-acetyllactosamines and sialyl-Lewis x on O-glycans 87
Two glycosphingolipid sialyltransferases are localized in different sub-Golgi compartments in rat liver 86
Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver 86
The N-acetylgalactosamine residue of exogenous GM2 ganglioside is recycled for glycoconjugate biosynthesis in rat liver 84
Incorporation and metebolism of exogenous GM1 ganglioside in rat liver 82
Different metabolic recycling of the lipid components of exogenous sulfatide in human fibroblasts 81
Subcellular biosynthesis and trasport of gangliosides formed from exogenous lactosylceramide in rat liver 81
Differential expression of b1,3galactosyltransferases in human colon cells derived from adenoarcinomas or normal mucosa 79
Effects of chronic desipramine treatment on alpha(2)-adrenoceptors and mu-opioid receptors in the guinea pig cortex and hippocampus 79
Localization in the Golgi apparatus of rat liver UDP-Gal: glucosylceramide beta1-4 galactosyltransferase 70
Mouse C127 cells transfected with fucosyltransferase Fuc-TIII express masked Lexis x but not Lewis x antigen 67
Functional interaction between alpha2-adrenoceptors, mu- and kappa-opioid receptors in the guinea pig myenteric plexus: effect of chronic desipramine treatment. 65
Recent advances in ganglioside metabolism 65
Analysis of the proximal promoter of the human colon-specific B4GALNT2 (Sda synthase) gene: B4GALNT2 is transcriptionally regulated by ETS1 64
In vitro ischaemia increases phosphorylation of NMDA receptor NR1 subunit in the myenteric plexus of the guinea pig ileum via protein kinase C 63
Simple and Complex Sugars in Parkinson’s Disease: a Bittersweet Taste 63
Topography of glycosyltransferases involved in the initial glycosylation of gangliosides 60
A novel nonsense and inactivating variant of ST3GAL3 in two infant siblings suffering severe epilepsy and expressing circulating CA19.9 56
Epigenetic regulation of glycosylation in cancer and other diseases 56
Epigenetic Regulation of Glycosylation 38
A sensitive method for determining UDP-glucose: ceramide glucosyltransferase (UGCG) activity in biological samples using deuterated glucosylceramide as acceptor substrate 33
Inhibition of ceramide synthesis reduces α‐synuclein proteinopathy in a cellular model of parkinson’s disease 23
Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism 2
Totale 6.039
Categoria #
all - tutte 20.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019343 0 0 0 0 0 0 0 0 0 0 127 216
2019/20201.169 49 48 52 227 81 124 180 136 85 91 20 76
2020/20211.005 21 85 71 87 58 78 40 83 132 71 84 195
2021/2022636 112 66 59 36 38 25 31 45 34 93 32 65
2022/2023810 58 44 35 93 57 177 3 83 103 30 113 14
2023/20241.149 189 198 184 222 224 57 3 12 48 8 4 0
Totale 6.039